Evaxion's EVX-B1 Vaccine Shows Promising Protection Against Staph Infections in Preclinical Studies
Evaxion's EVX-B1 Vaccine Shows Promising Protection Against Staph Infections in Preclinical Studies
Evaxion 的 EVX-B1 疫苗在臨床前研究中顯示出有望預防葡萄球菌感染的作用
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊